ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 52 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2017. The put-call ratio across all filers is 25.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $80,868,000 | -18.5% | 16,013,540 | 0.0% | 4.56% | +23.4% |
| Q3 2017 | $99,284,000 | +72.2% | 16,013,540 | 0.0% | 3.70% | +140.4% |
| Q2 2017 | $57,649,000 | +10.8% | 16,013,540 | 0.0% | 1.54% | -4.8% |
| Q1 2017 | $52,044,000 | +32.7% | 16,013,540 | 0.0% | 1.62% | +35.6% |
| Q4 2016 | $39,233,000 | -28.8% | 16,013,540 | 0.0% | 1.19% | -42.6% |
| Q3 2016 | $55,087,000 | -43.5% | 16,013,540 | 0.0% | 2.08% | -37.9% |
| Q3 2015 | $97,522,000 | – | 16,013,540 | – | 3.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |